All lobbying filings

KING & SPALDING LLP

KING & SPALDING LLP filed a Q3 amendment for MOLECULIGHT CORPORATION on October 19, 2025, reporting $30,000 in lobbying income.

Lobbying for MOLECULIGHT CORPORATION · Wound Care Solutions. Maker-MolecuLight i:X handheld wound imaging device for clinicians.

All filings by KING & SPALDING LLP · Everything MOLECULIGHT CORPORATION has reported

Filing · LD-2 quarterly report Q3 amendment

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 19, 2025

Income

$30,000

What the client paid this registrant for the period.

Client based in

Pennsylvania

Official filing document

Lobbyists on this filing 3

JULIA RICHARDSON

Previously held: 2022-2014 FEC Counsel to Commn. Chair & VP Chair; 2015- 2014 USCPSC Senior Counsel & Policy Advisor to Chairman; Director Office of Leg. Affts. 2009-2014 US Senate Comm. on Rules & Admin. Senior Counsel & Counsel
SCOTT DZIENGELSKI

Previously held: Rep. Murphy (PA-18): Leg. Dir. (2015-2017), Sr. Leg. Asst. (2013- 2015), Leg. Asst. (2012-2013), Leg. Corr. (2011-2012), Staff Asst. (2010-2011); Energy and Commerce Committee: Staff (2015-2017)
KENDRICK B MEEK Former member of Congress

Previously held: U.S. Representative (FL-17) 2002-2010)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Lobbying on Medicare coverage issues

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.